Diagnostics & Research
The Diagnostics & Research industry has a total of 63 stocks, with a combined market cap of $792.26 billion, total revenue of $155.97 billion and a weighted average PE ratio of 59.21.
Market Cap
792.26B
Revenue
155.97B
Profits
13.38B
PE Ratio
59.21
Profit Margin
8.58%
Dividend Yield
0.19%
63 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 228.66B | 0.71% | 1,188,726 | 42.49B |
| 2 | DHR | Danaher Corporation | 195.14B | 1.62% | 3,064,769 | 22.52B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.30B | 5.26% | 809,844 | 3.72B |
| 4 | A | Agilent Technologies, Inc. | 45.15B | 1.85% | 1,524,628 | 6.74B |
| 5 | IQV | IQVIA Holdings Inc. | 42.58B | 1.10% | 947,654 | 15.07B |
| 6 | MTD | Mettler-Toledo International Inc. | 32.51B | 1.59% | 126,681 | 3.79B |
| 7 | ICLR | ICON PLC | 26.61B | 1.97% | 476,568 | 8.23B |
| 8 | WAT | Waters Corporation | 21.46B | 0.78% | 421,271 | 2.91B |
| 9 | ILMN | Illumina, Inc. | 18.32B | -0.49% | 1,242,812 | 4.49B |
| 10 | LH | Laboratory Corporation of America Holdings | 17.97B | 0.95% | 521,641 | 12.30B |
| 11 | DGX | Quest Diagnostics Incorporated | 15.64B | 1.16% | 739,517 | 9.29B |
| 12 | RVTY | Revvity, Inc. | 13.24B | 0.73% | 1,410,871 | 2.73B |
| 13 | NTRA | Natera, Inc. | 13.12B | 1.70% | 1,130,935 | 1.21B |
| 14 | MEDP | Medpace Holdings, Inc. | 12.58B | 1.85% | 223,539 | 1.96B |
| 15 | CRL | Charles River Laboratories International, Inc. | 11.98B | -0.11% | 518,051 | 4.11B |
| 16 | QGEN | Qiagen N.V. | 10.13B | 0.84% | 1,309,341 | 1.94B |
| 17 | EXAS | Exact Sciences Corporation | 9.84B | -1.22% | 2,718,703 | 2.53B |
| 18 | RDNT | RadNet, Inc. | 4.30B | 2.66% | 352,919 | 1.66B |
| 19 | SHC | Sotera Health Company | 3.23B | 0.09% | 531,619 | 1.08B |
| 20 | GH | Guardant Health, Inc. | 3.14B | 4.12% | 2,357,859 | 603.73M |
| 21 | OLK | Olink Holding AB (publ) | 2.99B | 1.22% | 692,463 | 170.89M |
| 22 | NEOG | Neogen Corporation | 2.88B | 1.60% | 1,649,761 | 929.24M |
| 23 | TWST | Twist Bioscience Corporation | 2.82B | 0.48% | 1,076,642 | 277.49M |
| 24 | MYGN | Myriad Genetics, Inc. | 2.23B | -2.76% | 1,394,165 | 774.20M |
| 25 | NEO | NeoGenomics, Inc. | 1.93B | -1.75% | 1,072,711 | 610.66M |
| 26 | VCYT | Veracyte, Inc. | 1.80B | 2.30% | 719,051 | 375.47M |
| 27 | LAB | Standard BioTools Inc. | 969.11M | -0.39% | 2,743,803 | 126.76M |
| 28 | OPK | OPKO Health, Inc. | 940.94M | 3.45% | 3,120,491 | 799.60M |
| 29 | BNR | Burning Rock Biotech Limited | 848.35M | 2.88% | 5,904 | 75.80M |
| 30 | CDNA | CareDx, Inc | 769.80M | -3.02% | 722,940 | 275.11M |
| 31 | FLGT | Fulgent Genetics, Inc. | 675.39M | 1.12% | 127,986 | 287.53M |
| 32 | CSTL | Castle Biosciences, Inc. | 672.51M | 1.88% | 234,576 | 250.73M |
| 33 | ME | 23andMe Holding Co. | 282.51M | -4.24% | 3,295,456 | 247.99M |
| 34 | SERA | Sera Prognostics, Inc. | 267.00M | 0.96% | 137,122 | 206.00K |
| 35 | BDSX | Biodesix, Inc. | 174.90M | 2.01% | 75,875 | 54.85M |
| 36 | FONR | FONAR Corporation | 102.95M | -1.09% | 73,207 | 102.42M |
| 37 | PRPH | ProPhase Labs, Inc. | 98.06M | 1.38% | 32,875 | 28.72M |
| 38 | TTOO | T2 Biosystems, Inc. | 91.74M | 43.51% | 3,113,145 | 7.18M |
| 39 | ACRS | Aclaris Therapeutics, Inc. | 84.09M | - | 628,897 | 31.12M |
| 40 | MDXH | MDxHealth SA | 76.82M | -2.26% | 42,104 | 75.33M |
| 41 | PSNL | Personalis, Inc. | 74.27M | -5.92% | 225,322 | 74.15M |
| 42 | STIM | Neuronetics, Inc. | 72.89M | 1.67% | 257,426 | 73.23M |
| 43 | PRE | Prenetics Global Limited | 72.87M | -1.00% | 9,176 | 21.74M |
| 44 | VNRX | VolitionRx Limited | 64.61M | 4.92% | 97,279 | 797.03K |
| 45 | NOTV | Inotiv, Inc. | 57.77M | 5.66% | 1,035,613 | 585.17M |
| 46 | ENZ | Enzo Biochem, Inc. | 56.35M | 0.92% | 48,390 | 12.81M |
| 47 | OCX | OncoCyte Corporation | 39.43M | 1.72% | 32,358 | 1.50M |
| 48 | AWH | Aspira Women's Health Inc. | 34.33M | -4.14% | 38,576 | 9.15M |
| 49 | XGN | Exagen Inc. | 33.15M | 8.52% | 144,768 | 55.73M |
| 50 | BIAF | bioAffinity Technologies, Inc. | 21.65M | 0.53% | 88,285 | 4.94M |
| 51 | DMTK | DermTech, Inc. | 19.74M | -10.64% | 552,492 | 15.66M |
| 52 | PMD | Psychemedics Corporation | 14.92M | 0.75% | 2,816 | 21.60M |
| 53 | STRR | Star Equity Holdings, Inc. | 14.26M | -0.01% | 5,007 | 45.79M |
| 54 | MYNZ | Mainz Biomed B.V. | 13.96M | 1.51% | 225,582 | 895.48K |
| 55 | TRIB | Trinity Biotech plc | 12.70M | - | 22,955 | 56.83M |
| 56 | CHEK | Check-Cap Ltd. | 12.52M | -0.47% | 6,402 | - |
| 57 | CNTG | Centogene N.V. | 11.15M | -8.07% | 41,779 | 55.72M |
| 58 | GENE | Genetic Technologies Limited | 10.71M | 0.83% | 9,830 | 5.78M |
| 59 | PRPO | Precipio, Inc. | 9.17M | -2.93% | 1,625 | 15.81M |
| 60 | XWEL | XWELL, Inc. | 7.70M | 1.66% | 7,411 | 30.11M |
| 61 | NDRA | ENDRA Life Sciences Inc. | 3.21M | -3.17% | 104,186 | - |
| 62 | APDN | Applied DNA Sciences, Inc. | 2.55M | -7.79% | 61,412 | 5.52M |
| 63 | ISPC | iSpecimen Inc. | 2.44M | 14.12% | 1,098,305 | 9.27M |